| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 18, 2026 | Option exercise(M) | 31K | $9.88 | $307K | 71K |
| Aug 18, 2026 | Sell(S) | 31K | $20.05 | $622K | 40K |
| Aug 17, 2026 | Sell(S) | 38K | $19.85 | $753K | 44K |
| Aug 17, 2026 | Sell(S) | 4K | $19.94 | $75K | 40K |
| Aug 17, 2026 | Option exercise(M) | 38K | $9.88 | $375K | 79K |
| Aug 17, 2026 | Option exercise(M) | 3K | $9.88 | $28K | 82K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 18, 2026 | Option exercise(M) | 31K | — | $0 | 96K |
| Aug 17, 2026 | Option exercise(M) | 38K | — | $0 | 130K |
| Aug 17, 2026 | Option exercise(M) | 3K | — | $0 | 127K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001810417-26-000019) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Avalo Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.